Sunday, March 25, 2012

Therapy "Rheumatoid Arthritis" Coming Soon in Indonesia


Jakarta (ANTARA) - therapy for the treatment of "rheumatoid arthritis", inflammatory joint disease with pain that is very, very, soon in Indonesia, so people will have the antidote.

"Rheumatoid arthritis For many patients, treatment with current therapies do not treat pain and other signs of deterioration of the disease," said Harry Isbagio, President of the Association of Rheumatoid Indonesia, in Jakarta, Monday.


According to him, the disease afflicts more than 21 million people worldwide and the disease it causes distortion of the joints and reduce the function of the pain, stiffness and swelling.

In a further development of the disease can lead to joint destruction that can not be repaired and cause disability.

"The hallmark of systemic penyakitr was accompanied by fatigue, anemia, osteoporosis and may reduce life expectancy by affecting the vital organs of the system," he said.

PT Roche Indonesia, an affiliate of Roche Group announced plans to implementation of clinical research "tocilizumab", the first-line biological therapy inhibiting receptor "interleukin six" (IL-6) approved its use based on the largest clinical Rheumatoid Arthritis.

Patients living with the disease was expected demand for better treatment and understanding of the impact and burden of the conditions experienced by them.

PT Roche Indonesia, one of the world's leading companies in pharmaceuticals and diagnostics based research, the challenge is to conduct research that ended in mid-2011 that tocilizumab clinical studies of IL-6 receptor inhibitor.

Inge S. Kusuma, Head of Pharma, Roche Indonesia, said pengembangkan tocilizumab and unique mechanism is an important new option for patients who experienced disease Rheumatoid arthritis continue to deteriorate despite getting treatment.

"Clinical research is an important step forward, offering a new option for the people of Indonesia affected by this serious disease," he said.

Tocilizumab is an inhibitor of IL-6 monoclonal antibody to the first.

This clinical study will involve five centers, namely, in Jakarta, Bandung, Surabaya, Malang and Yogyakarta.

Dr. Bambang Setyohadi, principal investigator explained that the purpose of this clinical study was to test the efficacy and safety of new therapies and provide therapeutic opportunities for patients with Rheumatoid arthritis in Indonesia.

Tocilizumab has been studied in five phase 3 studies involving multi-nation of more than 4,000 patients.

Research indicates that tocilizumab, a single therapy that significantly reduces the signs or the result of Rheumatoid arthritis.

Do Not Ignore The Pain That comes Suddenly Stomach

Have you when to run the daily activities, was interrupted by a sudden Suddenly stomach pain, Might you think it's normal to have one meal before, but when the stomach is not lost and no desire to defecate, it is better to check further.

By the time you feel the source of abdominal pain from the lower right abdomen, you may be Suffering from appendicitis. Symptoms of appendicitis for more details, you can see ... ..


Appendicitis Occurs due to blocked channels so That the appendix the which accumulated fluid can cause the appendix wall tension. This Causes the bacteria to multiply in the wall of the appendix.

The result showed That 7% of the population suffered appendicitis in his life, usually found in the age of 10 to 30 years. In some cases of appendicitis due to hereditary factors, if one family had suffered from appendicitis is usually the family will be affected offspring as well. And lucky for most women Often Because of appendicitis suffered by men, about 1.4 times more frequently than in women.

The cause of appendicitis until now remained unclear. The factors most That Often Causes blockage in the appendix is ​​fekolit and enlargement of lymphoid glands. Blockage due to enlarged lymphoid glands is Often occur in children with diarrhea, cough and runny nose.

From the study it was found That the occurrence of appendicitis is less common for people always eat fiber WHO Because of its digestive tract launched.

The most Important of appendicitis is not to leak Patients appendix Because it is very dangerous and can cause death. If you have symptoms that i have explained above, consult a doctor Immediately Because It may Reduced the incidence of leakage and complications.